These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9004339)

  • 1. The effects of age, gender, and season on serotonergic function in healthy subjects.
    Golden RN; Gilmore JH; Ekstrom RD; Knight B; Ruegg RG; Miller HL; Carson SW
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Nov; 20(8):1315-23. PubMed ID: 9004339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity.
    Lykouras L; Markianos M; Hatzimanolis Y
    Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serotonergic responsiveness in neurocardiogenic syncope: a clomipramine test challenge.
    Theodorakis GN; Markianos M; Livanis EG; Zarvalis E; Flevari P; Kremastinos DT
    Circulation; 1998 Dec; 98(24):2724-30. PubMed ID: 9851959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study.
    Cordes J; Kahl KG; Werner C; Henning U; Regenbrecht G; Larisch R; Schmidt-Kraepelin C; Thünker J; Agelink MW; Löffler S; Hohlfeld T; Gaebel W; Klimke A
    Eur Arch Psychiatry Clin Neurosci; 2011 Dec; 261(8):567-73. PubMed ID: 21404115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B
    Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis.
    Cordes J; Larisch R; Henning U; Thünker J; Werner C; Orozco G; Mayoral F; Rivas F; Auburger G; Tosch M; Rietschel M; Gaebel W; Müller HW; Klimke A
    Depress Anxiety; 2009; 26(8):E111-9. PubMed ID: 19288582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
    Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J
    Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serotonergic function in endogeneity of depression].
    González-Pinto A; López-Ibor JJ; Sáiz J; Gutiérrez M; Figuerido JL; Elizagárate E; Pérez de Heredia JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):73-8. PubMed ID: 9245192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):172-6. PubMed ID: 12242578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between prolactin responses to ECT and dopaminergic and serotonergic responsivity in depressed patients.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):166-71. PubMed ID: 12242577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central serotonergic changes following antidepressant treatment: a neuroendocrine assessment.
    Leatherman ME; Ekstrom RD; Corrigan M; Carson SW; Mason G; Golden RN
    Psychopharmacol Bull; 1993; 29(2):149-54. PubMed ID: 8290659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clomipramine test and subtypes of depression].
    González-Pinto A; López Ibor JJ; Sáiz J; Gutiérrez M; Figuerido JL; García Godoy MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):303-9. PubMed ID: 9054201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of intravenous clomipramine on neurohormones in normal subjects.
    Golden RN; Hsiao J; Lane E; Hicks R; Rogers S; Potter WZ
    J Clin Endocrinol Metab; 1989 Mar; 68(3):632-7. PubMed ID: 2537340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome.
    Theodorakis GN; Markianos M; Zarvalis E; Livanis EG; Flevari P; Kremastinos DT
    J Am Coll Cardiol; 2000 Jul; 36(1):174-8. PubMed ID: 10898430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered prolactin response to clomipramine rechallenge in healthy subjects.
    Gilmore JH; Ruegg RG; Ekstrom RD; Knight B; Carson SW; Mason GA; Golden RN
    Biol Psychiatry; 1993 Dec; 34(12):885-8. PubMed ID: 8110915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal responses to dl-fenfluramine challenge are not blunted in seasonal affective disorder.
    Yatham LN; Michalon M
    Psychoneuroendocrinology; 1995; 20(4):433-8. PubMed ID: 8532826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response.
    Sallee FR; Vrindavanam NS; Deas-Nesmith D; Odom AM; Carson SW; Sethuraman G
    Biol Psychiatry; 1998 Oct; 44(7):562-7. PubMed ID: 9787880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower central serotonergic responsivity is associated with preclinical carotid artery atherosclerosis.
    Muldoon MF; Mackey RH; Sutton-Tyrrell K; Flory JD; Pollock BG; Manuck SB
    Stroke; 2007 Aug; 38(8):2228-33. PubMed ID: 17626900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity of the corticotropic axis to the serotoninergic agent clomipramine in obese women.
    Laferrère B; Lahlou N; Saltiel H; Roger M; Basdevant A; Oppert JM; Guy-Grand B
    Obes Res; 1994 Jul; 2(4):328-36. PubMed ID: 16353581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.